Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New epidural timing could cut breakthrough pain in labor for experienced moms

NCT ID NCT06580327

Symptom relief Sponsor: Holy Family Hospital, Nazareth, Israel Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving epidural pain medicine in programmed, hourly boluses (instead of a continuous drip) reduces sudden breakthrough pain during labor. About 186 women who have given birth before will be randomly assigned to one of the two methods. The goal is to see which approach keeps pain scores lower and reduces the need for extra pain relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine and fentanyl (epidural)
What this could lead to
If it works, this could lead to a more effective way to manage labor pain for women who have given birth before, reducing sudden breakthrough pain.
What could go wrong
This is a small, early-stage trial with 186 participants, so results may not apply to all women. The difference between the two methods may be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 186 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. multiparous women 2. Term pregnancy 3. Singleton 4. Vertex presentation 5. Latent phase (cervical dilatation less than 6 cm) 6. Epidural analgesia request 7. Visual Analogue Scale score greater than 40 Exclusion Criteria: 1. Estimated fetal weight greater than 4.0 kg 2. Intra uterine fetal death 3. Drug sensitivity 5\. Anomalous fetus 6. Contraindication for epidural analgesia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breakthrough pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breakthrough Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breakthrough pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Holy Family Hospital

    RECRUITING

    Nazareth, 1641100, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.